Deoxyfluoroguanosine
Alternative Names: FluorodeoxyguanosineLatest Information Update: 02 Jul 2023
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antivirals; Nucleosides; Small molecules
- Mechanism of Action DNA-directed RNA polymerase modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Influenza virus infections